Literature DB >> 7816616

The influence of imperfectly paired helices I and III on the catalytic activity of hammerhead ribozymes.

M Zoumadakis1, W J Neubert, M Tabler.   

Abstract

Several catalytic antisense RNAs directed against different regions of the genomic or antigenomic RNA of Sendai virus were constructed. All RNAs contained the same catalytic domain based on hammerhead ribozymes but some had deletions or mutations resulting in imperfect helices I and III. Pre-annealed substrate/ribozyme complexes were used to determine the rates of the cleavage process for the different ribozymes under single-turnover conditions. It was found that the sequence context surrounding the cleavable motif influenced the cleavage efficiencies. Deletions or mutations of nucleotides 2.1 or 15.1 and 15.2 according to the numbering system for hammerhead ribozymes of Hertel et al. destroyed catalytic activity. Deletions of nucleotide 2.2 or additional nucleotides in the helix I-forming region of the ribozyme did not destruct, but only reduced the cleavage efficiencies. Similar results were observed for a deletion of nucleotide 15.3. Simultaneous deletions within helices I and III resulted in alternative cleavage sites. The potential consequences for the specificity of the ribozyme reaction are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7816616      PMCID: PMC332071          DOI: 10.1093/nar/22.24.5271

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  Substrate sequence effects on "hammerhead" RNA catalytic efficiency.

Authors:  M J Fedor; O C Uhlenbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  Compilation of self-cleaving sequences from plant virus satellite RNAs and other sources.

Authors:  G Bruening
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

3.  Self-cleavage of virusoid RNA is performed by the proposed 55-nucleotide active site.

Authors:  A C Forster; R H Symons
Journal:  Cell       Date:  1987-07-03       Impact factor: 41.582

4.  High activity and stability of hammerhead ribozymes containing 2'-modified pyrimidine nucleosides and phosphorothioates.

Authors:  O Heidenreich; F Benseler; A Fahrenholz; F Eckstein
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

5.  Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages.

Authors:  T Shimayama; F Nishikawa; S Nishikawa; K Taira
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

6.  Sendai virus gene expression in lytically and persistently infected cells.

Authors:  H E Homann; P H Hofschneider; W J Neubert
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

7.  Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1.

Authors:  M Homann; S Tzortzakaki; K Rittner; G Sczakiel; M Tabler
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

8.  Kinetics of intermolecular cleavage by hammerhead ribozymes.

Authors:  M J Fedor; O C Uhlenbeck
Journal:  Biochemistry       Date:  1992-12-08       Impact factor: 3.162

9.  Linear oligomeric potato spindle tuber viroid (PSTV) RNAs are accurately processed in vitro to the monomeric circular viroid proper when incubated with a nuclear extract from healthy potato cells.

Authors:  M Tsagris; M Tabler; H P Mühlbach; H L Sänger
Journal:  EMBO J       Date:  1987-08       Impact factor: 11.598

10.  Cytoplasmic delivery of ribozymes leads to efficient reduction in alpha-lactalbumin mRNA levels in C127I mouse cells.

Authors:  P J L'Huillier; S R Davis; A R Bellamy
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  11 in total

1.  Unexpected anisotropy in substrate cleavage rates by asymmetric hammerhead ribozymes.

Authors:  P Hendry; M McCall
Journal:  Nucleic Acids Res       Date:  1996-07-15       Impact factor: 16.971

2.  In vitro selection of hammerhead ribozymes containing a bulged nucleotide in stem II.

Authors:  J B Thomson; S T Sigurdsson; A Zeuch; F Eckstein
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

3.  Comparative analysis of cleavage rates after systematic permutation of the NUX consensus target motif for hammerhead ribozymes.

Authors:  M Zoumadakis; M Tabler
Journal:  Nucleic Acids Res       Date:  1995-04-11       Impact factor: 16.971

4.  The effect of structure in a long target RNA on ribozyme cleavage efficiency.

Authors:  T B Campbell; C K McDonald; M Hagen
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

5.  Structural variants and modifications of hammerhead ribozymes targeting influenza A virus conserved structural motifs.

Authors:  Tomasz Czapik; Julita Piasecka; Ryszard Kierzek; Elzbieta Kierzek
Journal:  Mol Ther Nucleic Acids       Date:  2022-05-31       Impact factor: 10.183

6.  Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.

Authors:  L Q Sun; L Wang; W L Gerlach; G Symonds
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

7.  Rab11 and actin cytoskeleton participate in Giardia lamblia encystation, guiding the specific vesicles to the cyst wall.

Authors:  Araceli Castillo-Romero; Gloria Leon-Avila; Ching C Wang; Armando Perez Rangel; Minerva Camacho Nuez; Carlos Garcia Tovar; Jorge Tonatiuh Ayala-Sumuano; Juan Pedro Luna-Arias; Jose Manuel Hernandez
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

8.  A spermidine-induced conformational change of long-armed hammerhead ribozymes: ionic requirements for fast cleavage kinetics.

Authors:  C Hammann; R Hormes; G Sczakiel; M Tabler
Journal:  Nucleic Acids Res       Date:  1997-12-01       Impact factor: 16.971

9.  A strategy for developing a hammerhead ribozyme for selective RNA cleavage depending on substitutional RNA editing.

Authors:  Masatora Fukuda; Kei Kurihara; Yasuyoshi Tanaka; Masanobu Deshimaru
Journal:  RNA       Date:  2012-07-13       Impact factor: 4.942

10.  Variables and strategies in development of therapeutic post-transcriptional gene silencing agents.

Authors:  Jack M Sullivan; Edwin H Yau; Tiffany A Kolniak; Lowell G Sheflin; R Thomas Taggart; Heba E Abdelmaksoud
Journal:  J Ophthalmol       Date:  2011-06-30       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.